Wegovy 1.7mg is a prescription injection primarily used for long-term weight management in overweight or obese individuals. It contains the FDA-approved active ingredient Semaglutide, a GLP-1 (Glucose-Like Peptide-1) receptor antagonist. Novo Nordisk India Ltd manufactures the product.
Semaglutide imitates the natural GLP-1 hormone to help control appetite, lower calorie intake, and slow digestion, leading to weight loss. It also helps reduce the chance of serious heart events like heart attacks and strokes in overweight or obese individuals with existing heart disease.
Common side effects of Wegovy are nausea, vomiting, and diarrhea. Taking this medication with Insulin, Sulfonylureas, or Meglitinides may cause low blood sugar (hypoglycemia). Alcohol can worsen side effects and should be avoided.
Those with a history of pancreatitis or thyroid cancer should not use this medication due to potential risks. Always inform your doctor about all medications and health conditions to avoid complications. Only stop the medication under medical supervision.
The benefits of taking Wegovy 1.7 mg include:
Wegovy is a prescription-based medication that patients should take per the doctor’s instructions. Here are some general guidelines for this medication.
The strengths and substitutes available for Wegovy 1.7mg at Cheap Medicine Shop are:
| Wegovy 0.5mg | $270.58/injection |
| Wegovy 0.25mg | $270.58/injection |
The side effects of Wegovy 1.7mg include:
They are generally mild and will disappear as the body adjusts to the medication. However, if they continue or worsen, consult a doctor immediately.
Liver disease
This medication is usually safe for patients with mild to moderate liver disease when monitored by a doctor. However, those with severe liver issues may need dose adjustments.
Kidney impairment
Patients with kidney impairment should use this medication carefully, as gastrointestinal side effects may cause dehydration. A doctor should be consulted for possible dose changes and regular monitoring of kidney function.
Pregnancy and breastfeeding
Wegovy 1.7mg should be avoided during pregnancy as the weight-loss effect can be harmful to the fetus. Breastfeeding women should consult their doctor before use, and other treatment options may be explored.
Avoid
Avoid taking the medication if you are allergic to Semaglutide. Alcohol may increase the risk of side effects, which patients should avoid.
Wegovy 1.7 mg is not recommended for those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), thyroid cancer (MTC), allergies to Semaglutide, pregnant women, children under 12, users of other GLP-1 agonists, or those with Pancreatitis, severe gastrointestinal disease, or diabetic retinopathy. Consult a doctor before use.
Wegovy 1.7 mg starts acting soon after injection. Still, because the dose gradually increases over several weeks, visible weight loss typically begins within the first few weeks and becomes more significant over the months. When taken with diet and exercise, most patients see gradual, sustained weight loss of 5–15% or more of body weight within a year.
If you miss a dose of Wegovy 1.7 mg, take it as soon as you remember, if your next dose is more than 48 hours away. If less than 48 hours remain, skip the missed dose and continue your regular schedule. Do not take two doses within 48 hours. For missed doses over two weeks, consult your healthcare provider.
Eating smaller, more frequent meals and avoiding fatty or fried foods at the start of treatment can reduce side effects like nausea. Staying hydrated and resting can help with fatigue or dizziness. Consult your doctor if side effects worsen.
Wegovy 1.7 mg does not directly cause sleep disturbances like insomnia. But by promoting weight loss, Wegovy may improve sleep over time, particularly in people with obesity-related sleep issues like Obstructive Sleep Apnea (OSA).